missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. GABA-AR alpha 1 Antibody (1F4) - Chimeric - Azide and BSA Free, Novus Biologicals™
  7. 18660807

GABA-AR alpha 1 Antibody (1F4) - Chimeric - Azide and BSA Free, Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-09047-0.2mg

 View more versions of this product

Product Code. 18660807

  • £548.00 / 0.20mg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

GABA-AR alpha 1 Monoclonal antibody specifically detects GABA-AR alpha 1 in Human samples. It is validated for Immunocytochemistry/ Immunofluorescence, X-Ray Crystallography
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GABA-AR alpha 1
Monoclonal
1 mg/mL
PBS
Rabbit
Protein A purified
RUO
Primary
Human
Purified
Immunofluorescence, X-Ray Crystallography
1F4
Unconjugated
ECA4, EJM, EJM5GABA(A) receptor subunit alpha-1, gamma-aminobutyric acid (GABA) A receptor, alpha 1, gamma-aminobutyric acid receptor subunit alpha-1
This antibody was raised against alpha 1 beta 2 gamma 2 GABA-A receptor.
0.2 mg
Neuronal Cell Markers, Neuroscience, Neurotransmission
2554
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.